Additionally, the CEP55 protein expression was generally weak in early stage ovarian cancer (FIGO stages I and II), while it was strong in later stage ovarian cancer (FIGO stages III and IV) tissues (Fig. 3c). This evidence concerns the gene CEP55 and ovarian carcinoma.